|
|
Title | Last Updated |
A "State-of-the-Art" Conference on Hepatitis C |
May 6, 2008
|
A Case Study Approach to the Clinician's Challenge in Preserving Long-term Renal Function, Implication of Preserving Long-term Renal Function After Renal Transplantation, NIAID, NIH, DHHS |
Oct. 25, 2007
|
A Deadly Synergy |
April 1, 2005
|
A Delicate Balance: Levels of HIV Replication are Strongly Influenced by Interaction of Positive and Negative Host Factors |
July 9, 1996
|
A Framework for Progress on Hepatitis C |
May 6, 2008
|
A Helpful Guide to HIV and Metabolic Complications, NIAID, NIH, DHHS |
Oct. 28, 2008
|
A Killer Returns: The Face of the Epidemic |
April 1, 2005
|
A Leading Cause of Blindness May Be Controlled by Simple Course of Oral Antibiotic |
Aug. 19, 1999
|
A Microbe Hunter On Call to the World, Discovery News, NIAID, NIH |
May 9, 2008
|
A Multiple-reach Model Describing the Migratory Behavior of Snake River Yearling Chinook Salmon (Oncorhynchus tshawytscha), Can. J. Fish. Aquat. Sci. 55, 1998 |
Aug. 6, 2007
|
A New Gold Standard: Improved Animal Model Could Speed Drugs for Chagas’ Disease |
April 24, 2009
|
A New Registry for Primary Immune Deficiency Diseases |
Oct. 30, 1997
|
A Parasite, a Virus, and a Bacterium: NIAID's Plan to Tackle the World's Leading Killers, NIAID |
May 7, 2001
|
A Phase IIB randomized, controlled trial to evaluate the safety, tolerance, and HIV vertical transmission rates associated with short course nevirapine (NVP) vs. short course zidovudine (ZDV) in HIV infected pregnant women and their infants in Uganda |
July 15, 1999
|
A Potential New Target for Treating Asthma |
Dec. 1, 2006
|
A Safety Evaluation of MDCK for Influenza Vaccine Production, Vaccine Cell Substrate 2004, Practical Experience |
April 11, 2008
|
A Small Genetic Change Makes Flu Virus Deadly |
Sept. 6, 2001
|
A Timely Test: Real Time PCR |
March 24, 2009
|
A view from Washington through the eyes of an AAP physician-scientist, Anthony Fauci, Journal of Clinical Investigation, October 2007 |
Dec. 26, 2007
|
Abnormal Immune Cells May Cause Unprovoked Anaphylaxis |
Nov. 13, 2007
|
About CMB, Comparative Medicine Branch |
July 6, 2006
|
About NIAID |
June 26, 2009
|
About the Director, NIAID, NIH |
Aug. 4, 2009
|
About the Research Technologies Branch, NIAID, NIH |
Sept. 30, 2008
|
About the TB Bug, Tuberculosis, NIAID, NIH |
April 1, 2005
|
About, NIAID HIV and Emerging Infectious Diseases Program, NIAID, NIH |
Oct. 17, 2006
|
Abstract: “Enteric Vaccines for Pediatric Use” Workshop Report, April 24-26, 2004, NIAID, NIH |
Aug. 6, 2007
|
Abstract: “Hit” to Clinical Candidate: Discovery and Characterization of the Aminomethylcyclines |
Jan. 6, 2009
|
Abstract: Antiviral Drug Development for Biothreat Agents, Tove C. Bolken, Head of Research Operations, SIGA Technologies, Inc. |
Jan. 6, 2009
|
Abstract: Bacillus anthracis Antimicrobials Derived from Inhibitors of Mammalian Serine-Threonine Kinases, Jimmy D. Ballard, Ph.D. |
Jan. 6, 2009
|
Abstract: Challenges of Antibiotic Drug Development in the 21st Century, Karen Bush, Ph. D., |
Jan. 6, 2009
|
Abstract: Chop-lump Tests for Vaccine Trials, September 4, 2007 |
Sept. 20, 2007
|
Abstract: Combining Focused Antisense Screening Technology (FAST) and Structure-based Drug Design (SBDD) for Antibacterial Discovery |
Jan. 6, 2009
|
Abstract: Development of Antiviral RNA Interference Therapeutics, Antonin de Fougerolles |
Jan. 6, 2009
|
Abstract: Development of Cysteine Cathepsin Inhibitors as Anti-Ebola Virus Agents - James M. Cunningham |
Jan. 6, 2009
|
Abstract: Discovery of Smallpox Inhibitors that Block Processive DNA Synthesis |
Jan. 6, 2009
|
Abstract: Dose and Schedule Choices to Suppress Emergence of Resistance G.L. Drusano, M.D., Ordway Research Institute |
Jan. 6, 2009
|
Abstract: Efflux Pump Inhibitors: from Tools to Drugs |
Jan. 6, 2009
|
Abstract: Identification of Inhibitors of Ebola Virus Using a Subgenomic Replication System |
Jan. 6, 2009
|
Abstract: Identification of Small Molecule Inhibitors of Anthrax Lethal Factor |
Jan. 6, 2009
|
Abstract: Impact of Drug-Like Properties on Hit Selection and Optimization for Quality Clinical Candidates |
Jan. 6, 2009
|
Abstract: Leveraging Structure-Based Drug Design Technologies to Accelerate Drug Candidate Generation |
Jan. 6, 2009
|
Abstract: Multi-target Anthrax Antitoxin Therapies, February 7, 2007 |
Jan. 6, 2009
|
Abstract: Nucleotides as Anti-HBV Agents, R. P. Iyer, Ph.D. |
Jan. 6, 2009
|
Abstract: Old Target, New Approach: Developing Pterin-like Small Molecules as Inhibitors of the Bacterial Folate Pathway |
Jan. 6, 2009
|
Abstract: Optimizing the Oral Bioavailability and Activity of Antiviral Drugs, Karl Y. Hostetler |
Jan. 6, 2009
|
Abstract: Pitfalls of Target Validation for Novel Antibacterial Strategies, David J. Payne |
Jan. 6, 2009
|
Abstract: The Discovery of Orally Active Inhibitors of Respiratory Syncytial Virus, Nicholas A. Meanwell |
Jan. 6, 2009
|
Abstract: Use of a Cocktail to Reduce the Need for Drug Interaction Studies During Drug Development - Joseph S. Bertino Jr., Pharm.D., FCP |
Jan. 6, 2009
|
Acellular Pertussis Vaccine Proves Effective in Adults, Adolescents |
Oct. 12, 2005
|
Acquired Immunodeficiency Review Committee, About NIAID, NIAID, NIH |
July 22, 2004
|
Acquired Immunodeficiency Syndrome (AIDS), Selected Scientific Areas of Research |
Dec. 23, 2004
|
Acronyms, Comparative Medicine Branch |
July 2, 2006
|
ACTG 175, CPCRA 007 Trial Results Published |
Oct. 9, 1996
|
ACTG 175: Anti-HIV Therapy Lowers Risk of AIDS |
Sept. 14, 1995
|
ACTG 315 Preliminary Results: Drug Cocktail Restores Partial Immune Function |
Jan. 26, 1997
|
Active Clinical Trials |
Aug. 13, 2009
|
Actividades del Día de Concientización Sobre la Vacuna Contra el VIH/SIDA, 18 de mayo del 2005 |
July 30, 2007
|
Actividades del Día de Concientización Sobre las Vacunas Contra el VIH 18 de Mayo del 2006 |
July 30, 2007
|
Adaptively Changing Subgroup Proportions in Clinical Trials, Dean Follman, Statistica Sinica 1997 |
July 25, 2007
|
Add Your Voice, Division of AIDS (DAIDS), NIAID, NIH |
Oct. 1, 2008
|
Add Your Voice: Opportunties for Community Participation in HIV/AIDS Research, DAIDS, NIAID, NIH |
July 30, 2007
|
Adding IL-2 to Potent Anti-HIV Drugs Increases CD4+ T-Cell Counts Without Raising HIV Levels |
July 8, 2000
|
Additional Questions and Answers to RFP NIH-NIAID-DMID-PR2004-01 ‘Neutralizing Monoclonal Antibodies Type A for Botulinum Neurotoxins’ |
Oct. 1, 2008
|
Additional Questions and Answers to the RFP No. NIH-NIAID-DMID-PR2004-02, ‘Recombinant Type E Botulinum Neurotoxin Vaccine’ |
Oct. 1, 2008
|
Additional Resources, New Investigator Workshot, DAIT, NIAID, NIH |
Nov. 7, 2007
|
Adenovirus Potency Assays: Novel Approaches to Current Challenges |
April 11, 2008
|
Adjournment, National Advisory Allergy and Infectious Diseases Council January 2005 Minutes |
March 15, 2005
|
Adjournment, National Advisory Allergy and Infectious Diseases Council September 1997 Minutes |
March 13, 2001
|
Adjournment, National Advisory Allergy and Infectious Diseases Council: February 2000 Minutes |
March 2, 2001
|
Adjournment, National Advisory Allergy and Infectious Diseases Council: September 1998 Minutes |
March 12, 2001
|
Adjuvants and Other Vaccine Ingredients |
July 7, 2009
|
Adriana Marques, M.D., Clinical Studies Unit, Laboratory of Clinical Infectious Diseases, NIAID, NIH |
June 13, 2008
|
Adult Male Circumcision Reduces Risk of HIV Acquisition for at Least 3.5 Years |
Aug. 11, 2008
|
Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV: Trials in Kenya and Uganda Stopped Early |
Dec. 13, 2006
|
Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV: Trials in Kenya and Uganda Stopped Early |
Dec. 13, 2006
|
Advanced Product Development for Multiplex Infectious Disease Diagnostics: Summary of a NIAID Workshop |
Aug. 6, 2007
|
Advances in AIDS Pathogenesis and Preclinical Vaccine Development |
April 29, 1997
|
Adventitious Virus Tests, Vaccine Cell Substrates 2004, June 30, 2004 |
April 11, 2008
|
Advisory and Working Groups, HIV/AIDS Vaccines |
Jan. 14, 2009
|
Aedes Aegypti Announcement |
Jan. 5, 2006
|
Aedes Aegypti Announcement |
Jan. 5, 2006
|
Aedes Aegypti Sequencing Announcement |
Jan. 30, 2006
|
Aedes Announcement |
July 26, 2006
|
Africa Malaria Day and Malaria Awareness Day, April 25, 2007, NIAID, NIH |
April 25, 2007
|
African Americans Inspiring Hope |
May 17, 2005
|
African Americans: Answers about HIV Vaccine Research, NIAID, NIH |
Oct. 1, 2008
|
Age of Optimism |
Feb. 28, 2006
|
Age-Based Screening is Cost-Effective Method to Control Chlamydial Infection |
Feb. 17, 1998
|
Agenda, 40th Tuberculosis and Leprosy Research Conference, US-Japan Cooperative Medical Science Program, NIAID, NIH |
July 25, 2007
|
Agenda, Children and TB Drug Development, NIAID Workshop |
July 28, 2009
|
Agenda, Mycobacteria Symposium, NIAID, NIH |
Sept. 3, 2008
|
Agenda, NIAID Food Allergy Clinical Guideline Development Coordinating Committee Meeting, September 2, 2008 |
Oct. 28, 2008
|
Agenda, Pediatric Tuberculosis Meeting, NIAID, NIH |
June 3, 2008
|
Agenda, Vaccines for Viral Infections in Developing Countries |
Aug. 2, 2006
|
Agenda: 40th Tuberculosis and Leprosy Research Conference, US-Japan Cooperative Medical Science Program |
Aug. 6, 2007
|
Agenda: Prevention of Group A Streptococcal Diseases and Their Sequelae |
Aug. 16, 2007
|
Agricultural Workers at Increased Risk for Infection with Animal Flu Viruses |
Nov. 25, 2005
|
AIDS Care in Africa Meeting, Kampala, Uganda, April 18-20, 2001, Slide 18, Dr. Anthony S. Fauci, July 7, 2001 |
July 7, 2001
|
AIDS Clinical Trials Group: Affiliated Clinical Trials Units and Clinical Research Sites |
July 24, 2007
|
AIDS Deaths in the United States, 1985-2000, Slide 20, Dr. Anthony S. Fauci, July 7, 2001 |
July 7, 2001
|
AIDS Drugs Have Saved 3 Million Years of Life in the United States |
June 2, 2006
|
AIDS Research Advisory Committee, NIAID, NIH |
Jan. 5, 2009
|
AIDS Therapies Resource Guide |
July 8, 2009
|
AIDS Vaccine 2007 Report |
Jan. 8, 2008
|
AIDS Vaccine 2008 Report |
Jan. 6, 2009
|
AIDS Vaccine Research (AVR) Workshop Agenda, Sept 16-17, 2008 |
Oct. 28, 2008
|
AIDS Vaccine Research Highlights |
July 8, 1996
|
AIDS Vaccine Research Subcommittee (AVRS), Dec 2007, HIV/AIDS, Vaccines, DAIDS, NIAID, NIH |
June 23, 2008
|
AIDS Vaccine Research Subcommittee (AVRS), January 2009 |
July 7, 2009
|
AIDS Vaccine Research Subcommittee (AVRS), May 2008, HIV/AIDS, Vaccines, DAIDS, NIAID, NIH |
July 17, 2008
|
AIDS Vaccine Research Subcommittee (AVRS), September 2008, HIV/AIDS, Vaccines, DAIDS, NIAID, NIH |
Feb. 17, 2009
|
AIDS Vaccine Research Working Group (AVRWG) |
June 2, 2009
|
AIDS Vaccine Research Working Group (AVRWG) Committee Members |
Dec. 14, 2007
|
AIDS Vaccine Research Working Group Archived Meeting Summaries |
Oct. 18, 2007
|
AIDS Virus Reformatted to Shuttle Repair Genes to Diseased Brains |
April 11, 1996
|
AIDS.pdf |
June 11, 2009
|
Airborne Allergies: Something in the Air |
Feb. 12, 2008
|
Alan Sher, Immunobiology Section, Laboratory of Parasitic Diseases, NIAID, NIH |
Feb. 4, 2008
|
Alasdair M. Gilfillan, Ph.D., Mast Cell Biology Section, Laboratory of Allergic Diseases, NIAID, NIH |
July 8, 2008
|
Albert Z. Kapikian, M.D., Epidemiology Section, Laboratory of Infectious Diseases, NIAID, NIH |
May 22, 2006
|
Alfonso Gozalo, D.V.M., M.S., Veterinary Care, Comparative Medicine Branch, NIAID, NIH |
June 27, 2006
|
Alison McBride Ph.D., DNA Tumor Virus Section, Laboratory of Viral Diseases, NIAID, NIH |
Sept. 23, 2008
|
All About the VRC, VRC, NIAID, NIH |
Nov. 21, 2008
|
Allergic Diseases |
April 24, 2008
|
Allergic Diseases Clinical Studies |
Oct. 25, 2006
|
Allergic Diseases Introduction and Research Goals |
Oct. 24, 2006
|
Allergic Diseases Research Activities |
Feb. 19, 2008
|
Allergic Diseases Resources for Researchers |
Feb. 19, 2008
|
allergies.pdf |
June 11, 2009
|
Allergy / Immunology Fellowship Application Process, NIAID, NIH |
Dec. 26, 2007
|
Allergy and Asthma |
June 12, 2009
|
Allergy and Immunology Training Program in the Division of Intramural Research (DIR), NIAID, NIH |
Nov. 13, 2006
|
Allergy News Releases, NIAID, NIH |
May 11, 2009
|
Allergy, Immunology, and Transplantation Research Committee, About NIAID, NIAID, NIH |
March 9, 2005
|
ALPS and the Immune System, Autoimmune Lymphoproliferative Syndrome (ALPS) |
Oct. 7, 2008
|
ALPS and Your Family, Autoimmune Lymphoproliferative Syndrome (ALPS) |
Oct. 7, 2008
|
ALPS Workshop 2009 |
July 13, 2009
|
alpsFlyer.pdf |
Aug. 3, 2009
|
Alteration in Cell Death Pathway Sheds Light on Autoimmune Disease |
July 8, 1999
|
Amendment #1 (Questions and Answers) to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” |
Oct. 1, 2008
|
Amendment #1 (Questions and Answers) to RFP-NIH-NIAID-DMID-03-34, "Biodefense and Emerging Infections Research Resources Program" |
Oct. 1, 2008
|
Amendment #1 to RFP NIH-NIAID-DMID-03-54, “Construction Quality Management (CQM) Support Services” |
Oct. 1, 2008
|
Amendment #1 to RFP-NIH-NIAID-DAIT-04-38 |
Oct. 1, 2008
|
Amendment #1 to RFP-NIH-NIAID-DMID 04-34, "Bioinformatics Resource Centers for Biodefense and Emerging/Re-emerging Infectious Diseases" |
Oct. 1, 2008
|
Amendment #1 to RFP-NIH-NIAID-DMID-03-29, "Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine” |
Oct. 1, 2008
|
Amendment #1 to RFP-NIH-NIAID-DMID-03-45, "Administrative Resource for Biodefense Proteomic Centers" |
Oct. 1, 2008
|
Amendment #1, RFP NIH-NIAID-DMID-04-40, In Vitro and Animal Models for Emerging Diseases and BioDefense |
Oct. 1, 2008
|
Amendment #2 (Questions and Answers) to RFP-NIH-NIAID-DMID 04-34, "Bioinformatics Resource Centers for Biodefense and Emerging/Re-emerging Infectious Diseases" |
Oct. 1, 2008
|
Amendment #2 to RFP NIH-NIAID-DMID-03-45, “Administrative Resource for Biodenfense Proteomic Centers” |
Oct. 1, 2008
|
Amendment #2 to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” |
Oct. 1, 2008
|
Amendment #2 to RFP-NIH-NIAID-DMID-03-29, "Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine” |
Oct. 1, 2008
|
Amendment #2 to RFP-NIH-NIAID-DMID-03-34, "Biodefense and Emerging Infections Research Resources Program" |
Oct. 1, 2008
|
Amendment #3 to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” |
Oct. 1, 2008
|
Amendment #3 to RFP-NIH-NIAID-DMID 04-34 |
Oct. 1, 2008
|
Amendment #3 to RFP-NIH-NIAID-DMID-03-29 |
Oct. 1, 2008
|
Amendment #4 to RFP NIH-NIAID-DMID-BAA-03-38 |
Oct. 1, 2008
|
Amendment #4, to RFP NIH-NIAID-DMID-03-45, “Administrative Resource for Biodenfense Proteomic Centers” |
Oct. 1, 2008
|
Amendment #5 to RFP NIH-NIAID-DMID-BAA-03-38 |
Oct. 1, 2008
|
Amendment of NIAID Solicitation RFP NIH-NIAID-DMID-03-39, "In vitro and Animal Models for Emerging Diseases and Biodefense" |
Oct. 1, 2008
|
Amino Acid Analysis and Conjugation Efficiency Assays, Technology, Peptide Synthesis, Research Technologies Branch, NIAID, NIH |
July 7, 2009
|
An Ecologic Study of Prostate-specific Antigen Screening and Prostate Cancer Mortality in Nine Geographic Areas of the United States |
July 20, 2007
|
An HIV Vaccine — Evolving Concepts, NEJM, May 16, 2007 |
April 11, 2008
|
An HIV/AIDS Research Agenda in Developing Countries must be:, Slide 3, Dr. Esparza, July 7, 2001 |
July 6, 2001
|
An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-interferon Alfa 2b Every Two Weeks with Ribavirin Among HIV/HCV Coinfected Individuals |
July 16, 2009
|
Analyses, Technology, Mass Spectrometry, Research Technologies Branch, NIAID, NIH |
March 21, 2007
|
Analytical Chemistry |
July 8, 2009
|
Ancient immune mechanism identified that controls malaria in mosquitoes |
June 18, 2009
|
Animal Models for Experimental Therapeutics and Vaccines, Application Process, NIAID |
July 7, 2008
|
Animal Models for Experimental Therapeutics and Vaccines, Assurances to Users, NIAID |
July 7, 2008
|
Animal Models for Experimental Therapeutics and Vaccines, Eligibility Criteria, NIAID |
July 7, 2008
|
Animal Models for Hepatitis B and C, Application Process, NIAID |
July 3, 2008
|
Animal Models for Hepatitis B and C, Approval Process, NIAID |
July 3, 2008
|
Animal Models for Hepatitis B and C, Assurances to Users, NIAID |
July 2, 2008
|
Animal Models for Hepatitis B and C, Eligibility Criteria, NIAID |
July 2, 2008
|
Animal Models for Hepatitis B and C, NIAID |
July 14, 2008
|
Animal Models for the Evaluation of Experimental Therapeutics and Vaccines, Approval Process, NIAID |
July 7, 2008
|
Animal Models for the Evaluation of Experimental Therapeutics and Vaccines, NIAID |
July 14, 2008
|
Animal Models Speed TB Drug Development |
Aug. 10, 2009
|
Animal Models, HIV/AIDS Vaccine Research |
June 21, 2006
|
Animal Pharmacology and Toxicology |
July 8, 2009
|
Animal Studies |
July 17, 2008
|
Announcement of Availability of Overlapping Peptides for Influenza Proteome, January 27, 2006, Public Health Service, DHHS |
Oct. 1, 2008
|
Annual Commemorative Days, NIAID, NIH |
May 18, 2009
|
Anthony Fauci '58, Regis Alumni News Winter |
July 27, 2007
|
Anthony S. Fauci Awarded 2001 Frank Annunzio Award |
Oct. 4, 2001
|
Anthony S. Fauci Awarded Lasker Award for Public Service |
Sept. 14, 2007
|
Anthony S. Fauci Awarded the Highest Honor of the Association of American Physicians, NIAID, NIH |
April 13, 2007
|
Anthony S. Fauci to Present New Data on HIV Escape Mechanisms and HIV Suppressor Molecules |
Jan. 28, 1996
|
Anthony S. Fauci, M.D., Immunopathogenesis Section, Laboratory of Immunoregulation, NIAID, NIH |
May 12, 2008
|
Anthony S. Fauci, M.D., Lab Photo, 2007, NIAID, NIH |
April 13, 2007
|
Anthrax |
July 7, 2009
|
Anthrax Cause |
Sept. 4, 2007
|
Anthrax Genome Decoded |
April 30, 2003
|
Anthrax Overview |
July 7, 2009
|
Anthrax Prevention |
July 7, 2009
|
Anthrax Related Links |
June 17, 2009
|
Anthrax Research |
July 7, 2009
|
Anthrax Treatment |
July 7, 2009
|
Antibodies Gone Awry, Multiple Sclerosis |
Dec. 15, 2006
|
Antifungal Drug Helps Kids with Immune Disorder Avoid Hospitalization |
June 11, 2003
|
Antigen Development Unit, Malaria Vaccine Development Branch, NIAID, NIH |
Dec. 3, 2008
|
Antigenic Drift vs. Antigenic Shift, How the Flu Virus Changes,Flu (Influenza), NIAID, NIH |
Dec. 4, 2006
|
Antigenic Shift Illustration, How the Flu Virus Changes,Flu (Influenza), NIAID, NIH |
May 1, 2009
|
Anti-Herpes Drug Does Not Reduce Risk of HIV Infection in People with Genital Herpes Virus, Study Finds |
Feb. 6, 2008
|
Anti-HIV Gel Shows Promise in Large-scale Study in Women |
Feb. 9, 2009
|
Anti-HIV Treatment Improves Immune System and Fights Sight-Threatening Eye Infection |
Nov. 2, 1999
|
Antimicrobial (Drug) Resistance |
July 31, 2009
|
Antimicrobial (Drug) Resistance Research in NIAID Labs |
March 21, 2008
|
Antimicrobial (Drug) Resistance: A Growing Health Issue |
March 4, 2008
|
Antimicrobial Resistance - Selected Scientific Areas of Research |
Dec. 23, 2004
|
Antimicrobial Resistance News Releases, NIAID, NIH |
July 31, 2009
|
Antiretroviral Therapy (ART) to Reduce the Transmission of HIV |
April 21, 2008
|
Appendices - NIAID Profile FY 2003 |
Dec. 23, 2004
|
Appendices, NIAID Profile Fiscal Year 2004 |
Oct. 28, 2008
|
Appendices, NIAID Profile Fiscal Year 2005 |
Oct. 28, 2008
|
Appendix A: Aerosol System Flow |
April 27, 2009
|
Appendix A: Aerosol System Flow |
Oct. 9, 2007
|
Appendix A: Strategic Plan for Biodefense Research |
Sept. 7, 2007
|
Appendix B: Covered Sort Chamber |
Oct. 9, 2007
|
Appendix C: AeroTech Device |
Oct. 9, 2007
|
Appendix D: Position of the AeroTech Device |
Oct. 9, 2007
|
Appendix E: Glo-Germ |
Oct. 9, 2007
|
Appendix F: Collected Particles |
Oct. 9, 2007
|
Appendix G: Aerosol Cont. Report |
Oct. 9, 2007
|
Appendix H: Flow Lab Warning |
Oct. 9, 2007
|
Appendix I: Bio-Safety Suite |
Oct. 9, 2007
|
Appendix J: References |
Oct. 9, 2007
|
Application Information, Infectious Diseases Training Program, NIAID, NIH |
July 7, 2009
|
Application Information, Working at NIAID, NIH |
March 30, 2001
|
Application Process, Summer Internship Program in Biomedical Research |
May 1, 2009
|
Approaches to HIV Prevention, Slide 27, Dr. Anthony S. Fauci, July 7, 2001 |
July 7, 2001
|
Approaches to Potency Assays of Pre-and Prepro-Biologic Vaccines: The Role of RT-PCR and Genetic Stability in Characterizing Potency of Plasmnid DNA-based Vaccines |
April 11, 2008
|
Approved Anti-HIV Drugs, Slide 19, Dr. Anthony S. Fauci, July 7, 2001 |
July 7, 2001
|
Apr. 12, 2005 Pandemic Flu Posters |
Nov. 20, 2008
|
Apr. 12, 2005 Pandemic Flu Testimony |
Nov. 20, 2008
|
April 18, 2007 Biolshield Hearing Poster |
Nov. 21, 2008
|
April 18, 2007 Bioshield Congressional Testimony |
Nov. 21, 2008
|
Architectural Rendering, Building 33, NIAID, NIH |
May 1, 2006
|
Archive of Conferences and Meetings SummariesDivision of Allergy, Immunology, and Transplantation (DAIT), NIAID, NIH |
Aug. 9, 2005
|
Archive of NIAID in the News |
June 17, 2005
|
Archive of VRC Clinical Studies |
June 18, 2009
|
Archived Determination IND |
May 20, 2009
|
Archived Reports and Articles |
March 16, 2009
|
Archived Research Features, Flu (Influenza), NIAID, NIH |
Oct. 15, 2008
|
Arnold S. Kirshenbaum, M.D., Mast Cell Biology Section, Laboratory of Allergic Diseases, NIAID, NIH |
March 22, 2005
|
Article in Press, K.-L. Nguyen et al., Virology 2004 |
Aug. 1, 2007
|
Ascariasis |
July 7, 2009
|
Ascariasis Cause |
Sept. 13, 2007
|
Ascariasis Diagnosis |
July 7, 2009
|
Ascariasis Related Links |
June 17, 2009
|
Ascariasis Research |
Sept. 13, 2007
|
Ascariasis Symptoms |
Sept. 13, 2007
|
Ascariasis Transmission |
Sept. 13, 2007
|
Ascariasis Treatment |
Sept. 13, 2007
|
Asexual Blood-Stage Vaccines, Malaria Vaccine Development Branch, NIAID, NIH |
July 7, 2009
|
Ashish Jain, M.D., Clinical Immunology Unit, Laboratory of Host Defenses, NIAID, NIH |
March 12, 2008
|
Assay Requirements |
April 11, 2008
|
Assaying Potency of Novel Vaccines |
April 10, 2008
|
Assays For An AAV Vectored HIV Vaccine |
April 11, 2008
|
Assays for Bovine Viruses |
April 11, 2008
|
Association of American Physicians Presidential Address: The AIDS Model: Scientific and Policy Lessons for the 21st Century, Anthony S. Fauci |
July 19, 2007
|
Asthma |
May 5, 2009
|
Asthma and Allergic Diseases, Selected Scientific Areas of Research |
Dec. 23, 2004
|
Asthma Facts |
July 7, 2009
|
Asthma Networks, Partners, and Consortia |
July 7, 2009
|
Asthma News Releases |
Aug. 10, 2009
|
Asthma Research |
April 30, 2008
|
Asthma Research Activities and Resources |
April 29, 2008
|
Asthma Research Focus, NIAID, NIH |
July 7, 2009
|
Asthma Research in NIAID Labs |
April 29, 2008
|
Asthma Researchers Present New Results, New Perspectives on the Disease |
Feb. 25, 2002
|
asthma.pdf |
June 11, 2009
|
Attachment II: Safety Monitoring Committee (SMC) Guidelines, DMID, NIAID, NIH |
May 20, 2009
|
Attachment III: Independent Safety Monitor (ISM) Guidelines, NIAID, NIH |
May 20, 2009
|
Aug. 11, 2004 - Work on the Building Interior |
May 2, 2006
|
Augmented Designs to Assess Immune Response in Vaccine Trials |
Aug. 6, 2007
|
Autoimmune Disease New Releases |
Aug. 10, 2009
|
Autoimmune Diseases |
March 28, 2006
|
Autoimmune Diseases - Selected Scientific Areas of Research |
Dec. 23, 2004
|
Autoimmune Diseases Clinical Studies |
March 28, 2006
|
Autoimmune Diseases Related Publications and Links |
July 14, 2009
|
Autoimmune Diseases Research Activities |
Aug. 3, 2006
|
Autoimmune Diseases Research Plan, NIAID, NIH |
Sept. 14, 2007
|
Autoimmune Diseases Resources for Researchers |
March 28, 2006
|
Autoimmune Lymphoproliferative Syndrome (ALPS) |
July 31, 2009
|
Autoimmune Lymphoproliferative Syndrome (ALPS) Symptoms |
July 7, 2009
|
Autophagy Boosts BCG Protective Immunity |
June 17, 2009
|
Available TAACF Compounds, DMID Services for Researchers |
April 22, 2009
|
AVRS May 2007 Summary |
Oct. 19, 2007
|
AVRWG Advice on Adenovirus Vectors, Jan 07, DAIDS, NIAID, NIH |
Aug. 6, 2007
|
AVRWG Workshop Summary, January 07, DAIDS, NIAID, NIH |
Aug. 6, 2007
|
Award Will Boost HIV/AIDS Research in China |
June 28, 2002
|
Awardees, Medical Countermeasures Against Radiological and Nuclear Threats, NIAID, NIH |
June 8, 2009
|
AZT and AIDS |
July 7, 2009
|
|
|
|
|
|